Login / Signup

Efficacy and Safety of Teneligliptin 40 mg in Type 2 Diabetes: A Pooled Analysis of Two Phase III Clinical Studies.

Takashi KadowakiKazuyo SasakiManabu IshiiMiyuki MatsukawaYoshiteru Ushirogawa
Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2018)
Mitsubishi Tanabe Pharma Corporation.
Keyphrases
  • phase iii
  • type diabetes
  • open label
  • clinical trial
  • glycemic control
  • double blind
  • phase ii
  • placebo controlled
  • cardiovascular disease
  • insulin resistance
  • study protocol